Compile Data Set for Download or QSAR
Report error Found 100 Enz. Inhib. hit(s) with all data for entry = 2248
TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359101BDBM359101(US10220048, Compound AA11 | US10952992, No. AA11 |...)
Affinity DataIC50: 0.0100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359106BDBM359106(US10220048, Compound AA16 | US10952992, No. AA16 |...)
Affinity DataIC50: 0.0800nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359121BDBM359121(US10220048, Compound AA31 | US10952992, No. AA31 |...)
Affinity DataIC50: 0.0800nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359113BDBM359113(US10220048, Compound AA23 | US10952992, No. AA23 |...)
Affinity DataIC50: 0.0900nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359099BDBM359099(US10220048, Compound AA9 | US10952992, No. AA9 | U...)
Affinity DataIC50: 0.100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359104BDBM359104(US10220048, Compound AA14 | US10952992, No. AA14 |...)
Affinity DataIC50: 0.100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359118BDBM359118(US10220048, Compound AA28 | US10952992, No. AA28 |...)
Affinity DataIC50: 0.100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359117BDBM359117(US10220048, Compound AA27 | US10952992, No. AA27 |...)
Affinity DataIC50: 0.140nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359091BDBM359091(US10220048, Compound AA75 | US10220048, Compound A...)
Affinity DataIC50: 0.157nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359096BDBM359096(US10220048, Compound AA6 | US10952992, No. AA6 | U...)
Affinity DataIC50: 0.162nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359108BDBM359108(US10220048, Compound AA18 | US10952992, No. AA18 |...)
Affinity DataIC50: 0.200nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359187BDBM359187(US10220048, Compound AA97 | US10952992, No. AA97 |...)
Affinity DataIC50: 0.200nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359100BDBM359100(US10220048, Compound AA10 | US10952992, No. AA10 |...)
Affinity DataIC50: 0.200nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359178BDBM359178(US10220048, Compound AA88 | US10952992, No. AA88 |...)
Affinity DataIC50: 0.200nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359120BDBM359120(US10220048, Compound AA30 | US10952992, No. AA30 |...)
Affinity DataIC50: 0.200nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359131BDBM359131(US10220048, Compound AA41 | US10952992, No. AA41 |...)
Affinity DataIC50: 0.240nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359109BDBM359109(US10220048, Compound AA19 | US10952992, No. AA19 |...)
Affinity DataIC50: 0.300nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359138BDBM359138(US10220048, Compound AA48 | US10952992, No. AA48 |...)
Affinity DataIC50: 0.300nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359130BDBM359130(US10220048, Compound AA40 | US10952992, No. AA40 |...)
Affinity DataIC50: 0.300nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359105BDBM359105(US10220048, Compound AA15 | US10952992, No. AA15 |...)
Affinity DataIC50: 0.300nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359137BDBM359137(US10220048, Compound AA47 | US10952992, No. AA47 |...)
Affinity DataIC50: 0.300nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359167BDBM359167(US10220048, Compound AA77 | US10952992, No. AA77 |...)
Affinity DataIC50: 0.300nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359127BDBM359127(US10220048, Compound AA37 | US10952992, No. AA37 |...)
Affinity DataIC50: 0.400nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359115BDBM359115(US10220048, Compound AA25 | US10952992, No. AA25 |...)
Affinity DataIC50: 0.400nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359188BDBM359188(US10220048, Compound AA98 | US10952992, No. AA98 |...)
Affinity DataIC50: 0.600nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359107BDBM359107(US10220048, Compound AA17 | US10952992, No. AA17 |...)
Affinity DataIC50: 1nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359129BDBM359129(US10220048, Compound AA39 | US10952992, No. AA39 |...)
Affinity DataIC50: 1nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359098BDBM359098(US10220048, Compound AA8 | US10952992, No. AA8 | U...)
Affinity DataIC50: 1nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359114BDBM359114(US10220048, Compound AA24 | US10952992, No. AA24 |...)
Affinity DataIC50: 1nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359132BDBM359132(US10220048, Compound AA46 | US10220048, Compound A...)
Affinity DataIC50: 1nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359103BDBM359103(US10220048, Compound AA13 | US10952992, No. AA13 |...)
Affinity DataIC50: 1nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359119BDBM359119(US10220048, Compound AA29 | US10952992, No. AA29 |...)
Affinity DataIC50: 1nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359189BDBM359189(US10220048, Compound AA99 | US10952992, No. AA99 |...)
Affinity DataIC50: 2nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359122BDBM359122(US10220048, Compound AA32 | US10952992, No. AA32 |...)
Affinity DataIC50: 2nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359175BDBM359175(US10220048, Compound AA85 | US10952992, No. AA85 |...)
Affinity DataIC50: 2nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359182BDBM359182(US10220048, Compound AA92 | US10952992, No. AA92 |...)
Affinity DataIC50: 2nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359183BDBM359183(US10220048, Compound AA93 | US10952992, No. AA93 |...)
Affinity DataIC50: 2nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359128BDBM359128(US10220048, Compound AA38 | US10952992, No. AA38 |...)
Affinity DataIC50: 3nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359179BDBM359179(US10220048, Compound AA89 | US10952992, No. AA89 |...)
Affinity DataIC50: 3nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359185BDBM359185(US10220048, Compound AA95 | US10952992, No. AA95 |...)
Affinity DataIC50: 3nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359135BDBM359135(US10220048, Compound AA45 | US10952992, No. AA45 |...)
Affinity DataIC50: 3nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359092BDBM359092(US10220048, Compound AA2 | US10952992, No. AA2 | U...)
Affinity DataIC50: 4nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359124BDBM359124(US10220048, Compound AA34 | US10952992, No. AA34 |...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359125BDBM359125(US10220048, Compound AA35 | US10952992, No. AA35 |...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359139BDBM359139(US10220048, Compound AA49 | US10952992, No. AA49 |...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359112BDBM359112(US10220048, Compound AA22 | US10952992, No. AA22 |...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359094BDBM359094(US10220048, Compound AA4 | US10952992, No. AA4 | U...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359110BDBM359110(US10220048, Compound AA20 | US10952992, No. AA20 |...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359126BDBM359126(US10220048, Compound AA36 | US10952992, No. AA36 |...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

TargetReceptor-type tyrosine-protein phosphatase beta(Human)
Aerpio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 359095BDBM359095(US10220048, Compound AA5 | US10952992, No. AA5 | U...)
Affinity DataIC50: 5nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., Design and Synthesis of Potent, No...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent

Displayed 1 to 50 (of 100 total ) | Next | Last >>
Jump to: